Provided by Tiger Trade Technology Pte. Ltd.

Global X HealthTech ETF

29.49
+0.57551.99%
Volume:4K
Turnover:110.54K
Market Cap:30.95M
PE:- -
High:29.88
Open:29.33
Low:29.33
Close:28.91
52wk High:33.59
52wk Low:23.00
Shares:1.05M
Float Shares:1.05M
Volume Ratio:0.80
T/O Rate:0.36%
Dividend:0.07
Dividend Rate:0.25%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Dexcom Names Former Stryker CFO Glenn Boehnlein to Board

Reuters
·
Sep 11

Dexcom Appoints Glenn Boehnlein to Board of Directors

THOMSON REUTERS
·
Sep 11

IQVIA Announces Pricing of Senior Notes

THOMSON REUTERS
·
Sep 10

Iqvia. - Notes to Bear 6.375% Interest, Payable Semi-Annually from March 15, 2027

THOMSON REUTERS
·
Sep 10

Labcorp Holdings Inc. Stock Underperforms Wednesday When Compared to Competitors

Dow Jones
·
Sep 10

Tempus AI awarded up to $9.5M from ARPA-H for autonomous AI in cardiology

TIPRANKS
·
Sep 10

Tempus AI Wins up to $9.5 Million ARPA-H Advocate Award for Autonomous Heart Failure Agent

Reuters
·
Sep 10

Tempus Secures up to $9.5 Million in Arpa-H Advocate Funding to Deploy First Autonomous AI in Cardiology

THOMSON REUTERS
·
Sep 10

IQVIA backs real world pegcetacoplan study in rare kidney disease

TIPRANKS
·
Sep 10

Tempus AI Initiated at Neutral by UBS

Dow Jones
·
Sep 09

UBS Initiates Coverage on Tempus AI With Neutral Rating, $70 Price Target

MT Newswires Live
·
Sep 09

IQVIA Plans USD 2 Billion Senior Notes Offering Due 2034

Reuters
·
Sep 09

Iqvia. - Proceeds to Redeem Senior 5.000% Notes Due 2026 and Repay Revolving Credit Facility

THOMSON REUTERS
·
Sep 09

Iqvia. - to Offer $2 Bln Senior Notes Due 2034

THOMSON REUTERS
·
Sep 09

BrainAurora defines optimal pediatric doses for cognitive digital therapeutics in major BMC Medicine study

TIPRANKS
·
Sep 09

IQVIA Sees U.S. MASH Diagnostics Using Genfit Technology Topping USD 1.5 Billion Sales by 2033

Reuters
·
Sep 09

Centene Corp. Stock Underperforms Tuesday When Compared to Competitors

Dow Jones
·
Sep 09

Gartner Inc. Stock Slips 7.4%, Underperforms Peers

Dow Jones
·
Sep 09

ABL Diagnostics Delivers Surging Profits as Scale‑Up Strategy Takes Hold

TIPRANKS
·
Sep 09

Tempus AI Price Target Announced at $67.00/Share by Roth Capital

Dow Jones
·
Sep 08